MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Pay-per-Click New!
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Companies

Labtec GmbH

Labtec GmbH
Labtec GmbH provides innovative Product Development and Manufacturing Services all over the world.

The company in detail

Profile

Our technology platforms are

• transdermal patches
• topical patches
• oral dissolvable films
• buccal films

At your service for

• contract development
• contract manufacturing joint developments

Labtec GmbH provides innovative Product Development and Manufacturing Services all over the world. As a 100% subsidiary of tesa SE, Hamburg, Labtec formed itself to a leader in the field of development and making of transdermal patches and oral films.

You can find Labtec's proprietary products, marketed through our business partners, among the most successful brands in Europe and they are also progressing well in the global markets.

Labtec works at two sites. R&D is located in Langenfeld, between Cologne and Düsseldorf with state of the art cGMP lab facilities and vast analytical lab space. In Hamburg, inside tesa´s biggest German manufacturing plant, is the site for pilot and large scale manufacturing of patches and oral films. The new production site started operations in early 2009.
It works in compliance with cGMP standards and offers sufficient room for future expansion

With the skilled and experienced staff together with a strong and well established network of professional experts Labtec handles developments starting from feasibility study, technical issues, clinical and regulatory activities until manufacturing of the products.

Out-licensing

3-day transdermal system for treatment of Alzheimer´s disease More
5 and 10 mg Donepezil as well as 4 and 8 mg Ondansetron are under final development using the proprietary RapidFilm drug delivery Technology securing fast dissolution in the oral cavity without the need of water More
Lip patch containing herbal ingredients for treamtent of Herpes labialis / cold sores More
7-day transdermal patch for treatment of Parkinson´s disease More
Transdermal pain patch for the treatment of moderate to severe chronic pain. More

Press Releases

(26th Nov 2008) tesa AG, based in Hamburg, has acquired Labtec Gesellschaft für technologische Forschung und Entwicklung mbH More
(4th Aug 2008) A new innovative product near registration filing in cancer supportive care More
(29th Jan 2008) APR and Labtec Announce the Successful Completion of the Pilot Bioequivalence Study of Their Donepezil RapidFilm Further Confirming the Validity and Adaptability of This Innovative Proprietary Technology More
(15th Jan 2008) APR and Labtec announce the successful completion of the Pivotal Bioequivalence study for Ondansetron RapidFilm™ More
(25th Apr 2007) Labtec GmbH (Langenfeld, Germany), a specialty pharmaceutics company announces positive results from a multiple dose clinical study for their proprietary Sufentanil transdermal patch. More
(5th Jan 2007) First continuous combined hormone replacement patch approved for marketing in Europe More
(29th Sep 2006) Labtec´s licensee ratiopharm started marketing in Canada a transdermal patch containing fentanyl for treatment of strong chronic pain, which is generic to J&J´s blockbuster Durogesic®. More
(14th Mar 2006) Technology Catalysts International has identified oral thin films as a breakthrough technology that accelerates pharmaceutical product market introductions. More
More press releases

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2010 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us